Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1989 2
1993 1
1994 2
1995 1
2011 1
2013 1
2015 1
2016 1
2017 1
2018 2
2020 1
2021 1
2022 3
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

20 results
Results by year
Filters applied: . Clear all
Page 1
Phase 3, long-term, open-label extension period of safety and efficacy of belimumab in patients with systemic lupus erythematosus in China, for up to 6 years.
Zhang F, Zheng J, Li Y, Wang G, Wang M, Su Y, Gu J, Li X, Bass D, Chu M, Curtis P, DeRose K, Kurrasch R, Lowe J, Meizlik P, Roth DA. Zhang F, et al. Among authors: kurrasch r. RMD Open. 2022 Apr;8(1):e001669. doi: 10.1136/rmdopen-2021-001669. RMD Open. 2022. PMID: 35428697 Free PMC article. Clinical Trial.
Oral disease associated with dry eyes.
Kurrasch RH, Wu AJ, Fox PC. Kurrasch RH, et al. Int Ophthalmol Clin. 1994 Winter;34(1):89-100. doi: 10.1097/00004397-199403410-00009. Int Ophthalmol Clin. 1994. PMID: 8169075 Review. No abstract available.
Prednisone and piroxicam for treatment of primary Sjögren's syndrome.
Fox PC, Datiles M, Atkinson JC, Macynski AA, Scott J, Fletcher D, Valdez IH, Kurrasch RH, Delapenha R, Jackson W. Fox PC, et al. Among authors: kurrasch rh. Clin Exp Rheumatol. 1993 Mar-Apr;11(2):149-56. Clin Exp Rheumatol. 1993. PMID: 8508556 Clinical Trial.
Efficacy and safety of monotherapy with sirukumab compared with adalimumab monotherapy in biologic-naïve patients with active rheumatoid arthritis (SIRROUND-H): a randomised, double-blind, parallel-group, multinational, 52-week, phase 3 study.
Taylor PC, Schiff MH, Wang Q, Jiang Y, Zhuang Y, Kurrasch R, Daga S, Rao R, Tak PP, Hsu B. Taylor PC, et al. Among authors: kurrasch r. Ann Rheum Dis. 2018 May;77(5):658-666. doi: 10.1136/annrheumdis-2017-212496. Epub 2018 Feb 26. Ann Rheum Dis. 2018. PMID: 29483080 Clinical Trial.
A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Sirukumab in the Treatment of Giant Cell Arteritis.
Schmidt WA, Dasgupta B, Luqmani R, Unizony SH, Blockmans D, Lai Z, Kurrasch RH, Lazic I, Brown K, Rao R. Schmidt WA, et al. Among authors: kurrasch rh. Rheumatol Ther. 2020 Dec;7(4):793-810. doi: 10.1007/s40744-020-00227-2. Epub 2020 Aug 25. Rheumatol Ther. 2020. PMID: 32844378 Free PMC article.
20 results